Colleen F. Reitan

Companies

• Myriad GeneticsBoard member Sep 27, 2019 to now¹
• Alnylam PharmaceuticalsBoard member Jun 4, 2018 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Myriad Genetics MYGN152,030 shares³$631.7K at $4.16Jun 4, 2026
• Alnylam Pharmaceuticals ALNY1,446 shares⁴$340.6K at $235.58May 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 4, 2026Granted 59,701 shares of Myriad Genetics³
• May 20, 2026Granted 671 shares of Alnylam Pharmaceuticals⁴
• Sep 9, 2025Sold 25 shares at $480.98 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,386 shares at $479.55 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,450 shares at $478.67 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,183 shares at $477.47 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 972 shares at $476.31 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 951 shares at $474.85 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 838 shares at $474.22 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 823 shares at $472.82 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 222 shares at $471.25 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 799 shares at $464.36 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,652 shares at $463.00 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 2,290 shares at $461.92 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 473 shares at $460.71 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,403 shares at $459.73 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,888 shares at $458.86 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Sold 1,645 shares at $457.44 of Alnylam Pharmaceuticals⁵
• Sep 9, 2025Exercised options 18,000 shares at $100.65 of Alnylam Pharmaceuticals⁵
• Jun 5, 2025Granted 49,796 shares of Myriad Genetics⁶
• May 8, 2025Granted 775 shares of Alnylam Pharmaceuticals⁷
• Apr 16, 2025Sold 36 shares at $232.86 of Alnylam Pharmaceuticals⁷
• Oct 17, 2024Bought 4 shares at $302.67 of Alnylam Pharmaceuticals⁷
• Sep 3, 2024Sold 46,012 shares at $27.95 of Myriad Genetics⁸
• Aug 29, 2024Bought 32 shares at $286.00 of Alnylam Pharmaceuticals⁷